Monument Capital Management Takes Position in Cigna Group $CI

Monument Capital Management acquired a new stake in Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 644 shares of the health services provider’s stock, valued at approximately $213,000.

A number of other hedge funds also recently made changes to their positions in the business. Flaharty Asset Management LLC bought a new stake in shares of Cigna Group in the 1st quarter worth about $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group in the 1st quarter worth about $29,000. Activest Wealth Management grew its holdings in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares during the last quarter. Retirement Wealth Solutions LLC grew its holdings in shares of Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after purchasing an additional 43 shares during the last quarter. Finally, Saudi Central Bank bought a new stake in shares of Cigna Group in the 1st quarter worth about $36,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the topic of several analyst reports. Robert W. Baird set a $372.00 target price on shares of Cigna Group in a report on Thursday, August 14th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $371.00 target price on shares of Cigna Group in a report on Thursday, June 26th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday. Wells Fargo & Company upped their target price on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a report on Tuesday. Finally, Truist Financial set a $375.00 price objective on shares of Cigna Group in a report on Tuesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $372.69.

Cigna Group Stock Performance

Cigna Group stock opened at $301.00 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 1 year low of $256.89 and a 1 year high of $358.88. The company has a market cap of $80.35 billion, a PE ratio of 16.43, a PEG ratio of 0.90 and a beta of 0.45. The company’s 50-day moving average is $294.68 and its two-hundred day moving average is $309.31.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the prior year, the company posted $6.72 EPS. The company’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio is presently 32.97%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.